WO2002018435A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
18 human secreted proteins
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
PT1076703E
(en)
|
1998-05-15 |
2007-10-10 |
Genentech Inc |
Therapeutic uses of il-17 homologous polypeptides
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
JP2003508011A
(en)
*
|
1999-02-25 |
2003-03-04 |
トマス・ジエフアーソン・ユニバーシテイ |
Compositions, kits and methods relating to a novel tumor suppressor gene that is the human FEZ1 gene
|
WO2000050458A1
(en)
*
|
1999-02-26 |
2000-08-31 |
Smithkline Beecham Corporation |
Cloning of a p2y-like 7tm receptor (axor17)
|
CA2365238A1
(en)
*
|
1999-03-23 |
2000-09-28 |
Human Genome Sciences, Inc. |
48 human secreted proteins
|
EP1174509A4
(en)
|
1999-03-29 |
2003-10-22 |
Kansai Tech Licensing Org Co |
Novel cytidine deaminase
|
EP1892249A1
(en)
*
|
1999-09-01 |
2008-02-27 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20020151047A1
(en)
*
|
2001-01-08 |
2002-10-17 |
Yi Hu |
Novel human protease and polynucleotides encoding the same
|
US7083944B1
(en)
*
|
1999-10-27 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Molecules of the card-related protein family and uses thereof
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
EP1878794A3
(en)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP2004522404A
(en)
*
|
1999-12-01 |
2004-07-29 |
ジェネンテック・インコーポレーテッド |
Secreted and transmembrane polypeptides and nucleic acids encoding them
|
CN1300781A
(en)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
CA2398064C
(en)
|
2000-01-26 |
2012-12-18 |
Agensys, Inc. |
84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
WO2001096542A2
(en)
*
|
2000-06-15 |
2001-12-20 |
Millennium Pharmaceuticals, Inc. |
A human aminotransferase (23680) and uses thereof
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
JP2003527860A
(en)
*
|
2000-03-23 |
2003-09-24 |
イミューソル インコーポレイテッド |
BRCA-1 regulatory factors and methods of use
|
EP1272640A2
(en)
|
2000-03-24 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
EP1276873A2
(en)
*
|
2000-04-25 |
2003-01-22 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
EP1280917A2
(en)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
US20030096313A1
(en)
*
|
2000-05-12 |
2003-05-22 |
Burkhard Scharm |
Novel serine-threonine kinase-4
|
WO2001090160A2
(en)
*
|
2000-05-26 |
2001-11-29 |
Bayer Aktiengesellschaft |
REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
|
EP1158001B1
(en)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
|
DE10027170A1
(en)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Human PEM as a target for fertility control
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
WO2001094385A2
(en)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Human hm74-like g protein coupled receptor
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
WO2001096390A2
(en)
*
|
2000-06-09 |
2001-12-20 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
EP1290193A2
(en)
*
|
2000-06-16 |
2003-03-12 |
Incyte Genomics, Inc. |
Protein phosphatases
|
CA2648048A1
(en)
*
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
WO2002000861A2
(en)
*
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
Human beta-ketoacyl synthase (46619) and uses thereof
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
WO2002000691A2
(en)
*
|
2000-06-27 |
2002-01-03 |
Curagen Corporation |
Polynucleotides and polypeptides encoded thereby
|
US6774223B2
(en)
|
2000-06-28 |
2004-08-10 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
US6900303B2
(en)
|
2000-06-30 |
2005-05-31 |
Millennium Pharmaceuticals, Inc. |
57658, a novel human uridine kinase and uses thereof
|
WO2002004510A2
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Gtp-binding proteins
|
WO2002004520A2
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
AU2001275944A1
(en)
*
|
2000-07-14 |
2002-01-30 |
Millennium Pharmaceuticals, Inc. |
62088, a human nucleoside phosphatase family member and uses thereof
|
US20030171324A1
(en)
*
|
2000-07-18 |
2003-09-11 |
Shyam Ramakrishnan |
Regulation of human desc1-like serine protease
|
WO2002006318A2
(en)
|
2000-07-18 |
2002-01-24 |
Board Of Regents, The University Of Texas System |
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
|
CA2416456A1
(en)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20060252034A1
(en)
*
|
2000-07-25 |
2006-11-09 |
Klaus Duecker |
Novel protein containing ring finger domaine r1p4
|
WO2002008282A2
(en)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
WO2002008281A2
(en)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Bstp-cad protein and related reagents and methods of use thereof
|
EP1657254A3
(en)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
CA2416732C
(en)
|
2000-08-02 |
2016-02-09 |
Brad St. Croix |
Endothelial cell expression patterns
|
EP1315431A1
(en)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
A human gtp-releasing factor family member (15368) and uses therefor
|
US6924364B2
(en)
|
2000-08-04 |
2005-08-02 |
Zymogenetics, Inc. |
Human secreted protein, Zzp1
|
AU2001281252A1
(en)
|
2000-08-10 |
2002-02-18 |
Board Of Regents, The University Of Texas System |
The tumor suppressor car-1
|
EP1307566A2
(en)
*
|
2000-08-11 |
2003-05-07 |
MERCK PATENT GmbH |
Mitogen activated kinase
|
EP1326985A1
(en)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification of a human n-terminal acetyltransferase gene
|
WO2002016587A2
(en)
*
|
2000-08-21 |
2002-02-28 |
Incyte Genomics, Inc. |
Microtubule-associated proteins and tubulins
|
AU2001285102A1
(en)
|
2000-08-21 |
2002-03-04 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
AU2001284655A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
WO2002018578A2
(en)
|
2000-08-28 |
2002-03-07 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
AU2001284176A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
US20030224396A1
(en)
*
|
2000-08-30 |
2003-12-04 |
Yonghong Xiao |
Regulation of human aminotransferase-like enzyme
|
US20020091238A1
(en)
*
|
2000-08-30 |
2002-07-11 |
Curtis Rory A.J. |
54370, a novel human sulfate transporter and uses therefor
|
US20020146800A1
(en)
*
|
2000-08-30 |
2002-10-10 |
Curtis Rory A.J. |
48921, a novel human GTP releasing factor and uses therefor
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
WO2002018582A2
(en)
*
|
2000-08-31 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
CA2421588C
(en)
*
|
2000-09-05 |
2010-01-26 |
Amgen Inc. |
Tnf receptor-like molecules and uses thereof
|
CA2421265A1
(en)
*
|
2000-09-05 |
2002-03-14 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
US20020142464A1
(en)
*
|
2000-09-08 |
2002-10-03 |
Millennium Pharmaceuticals, Inc. |
38646, a novel guanine nucleotide exchange factor and uses therefor
|
US6372468B1
(en)
*
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
US20040048245A1
(en)
*
|
2000-10-05 |
2004-03-11 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
AU2002211597A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Millennium Pharmaceuticals, Inc. |
8843, a human dual specificity phosphatase family member and uses therefor
|
WO2002031126A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
US20020064831A1
(en)
*
|
2000-10-12 |
2002-05-30 |
The Texas A&M University System |
Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use
|
CA2425569A1
(en)
*
|
2000-10-13 |
2002-04-18 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
AU2002249787A1
(en)
|
2000-10-25 |
2002-08-19 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
WO2002036781A2
(en)
*
|
2000-10-31 |
2002-05-10 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
WO2002040672A2
(en)
|
2000-11-20 |
2002-05-23 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
AU2001297765A1
(en)
*
|
2000-12-05 |
2002-10-21 |
Incyte Genomics, Inc. |
Ligases
|
JP2004524825A
(en)
|
2000-12-07 |
2004-08-19 |
ザイモジェネティクス,インコーポレイティド |
Adipocyte complement-related protein ZACRP3X2
|
CA2430379A1
(en)
|
2000-12-07 |
2002-06-13 |
Chiron Corporation |
Endogenous retroviruses up-regulated in prostate cancer
|
WO2002048328A2
(en)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
ATE329027T1
(en)
|
2000-12-22 |
2006-06-15 |
Brystol Myers Squibb Company |
HUMAN LEUCINE-RICH REPEATS CONTAINING PROTEIN EXPRESSED PRIMARY IN THE SMALL INTESTINE, HLRRSI1
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6423521B1
(en)
*
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
WO2002053591A1
(en)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Mammalian nuclear receptor cofactor cf12 and methods of use
|
US20030219739A1
(en)
*
|
2001-01-30 |
2003-11-27 |
Glass David J. |
Novel nucleic acid and polypeptide molecules
|
EP1409536A2
(en)
*
|
2001-02-12 |
2004-04-21 |
Curagen Corporation |
Human proteins and nucleic acids encoding same
|
EP1637601A3
(en)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
AU2002250143A1
(en)
*
|
2001-03-16 |
2002-10-03 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
WO2002083919A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US20040003418A1
(en)
|
2001-04-10 |
2004-01-01 |
Aya Jakobovits |
Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
|
US20040175763A1
(en)
*
|
2001-04-24 |
2004-09-09 |
Hiroshi Saito |
Crohn's disease antibody-binding peptide and method of examining crohn's disease
|
US20050123910A1
(en)
*
|
2001-04-24 |
2005-06-09 |
Cookson William Osmond C.M. |
Enzyme and snp marker for disease
|
KR100817467B1
(en)
|
2001-05-07 |
2008-03-31 |
시오노기세이야쿠가부시키가이샤 |
Polypeptide serving as angiogenic marker and dna thereof
|
WO2002090543A2
(en)
*
|
2001-05-09 |
2002-11-14 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
AU2002311535A1
(en)
*
|
2001-06-26 |
2003-01-08 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
US20030120040A1
(en)
|
2001-06-29 |
2003-06-26 |
Genentech, Inc. |
Secreted and Transmembrane polypeptides and nucleic acids encoding the same
|
GB2399087A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ7
|
US20050176944A1
(en)
*
|
2001-08-17 |
2005-08-11 |
Henry Yue |
Intracellular signaling molecules
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
WO2003023063A1
(en)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Method of judging onset risk of diabetes
|
WO2003025175A2
(en)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
|
WO2003040369A2
(en)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
|
WO2003029411A2
(en)
|
2001-09-28 |
2003-04-10 |
Brigham Young University |
Novel cyclooxygenase variants and methods of use
|
WO2003038087A1
(en)
|
2001-10-04 |
2003-05-08 |
Kansai Technology Licensing Organization Co., Ltd. |
DR5 GENE PROMOTER AND Siah-1 GENE PROMOTER
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003031607A1
(en)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation of human short-chain dehydrogenase/reductase
|
DE60220621T2
(en)
|
2001-11-09 |
2008-03-06 |
Proteologics, Inc. |
Posh nucleic acid, polypeptides and related methods
|
AU2002365162A1
(en)
|
2001-11-14 |
2003-07-09 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
JPWO2003044197A1
(en)
*
|
2001-11-21 |
2005-03-24 |
独立行政法人科学技術振興機構 |
Huntington's disease gene transcription factor
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
WO2003051911A2
(en)
*
|
2001-12-19 |
2003-06-26 |
Genset S.A. |
Gmg-5 polynucleotides and polypeptides and uses thereof
|
JP2003245084A
(en)
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
|
DE10163467A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
WO2003057870A1
(en)
*
|
2002-01-07 |
2003-07-17 |
Bayer Healthcare Ag |
Human phosphatidic acid phosphatase type 2-like protein
|
WO2003060109A2
(en)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Human subtilisin/kexin-like convertase
|
AU2003205611A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Medigene Ag |
Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
|
JPWO2003062429A1
(en)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
New serine protease
|
WO2003070749A2
(en)
|
2002-02-15 |
2003-08-28 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
EP1338609A1
(en)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
A further KDR receptor and the use thereof
|
EP1497311A2
(en)
*
|
2002-03-05 |
2005-01-19 |
Applera Corporation |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
WO2003074557A1
(en)
*
|
2002-03-06 |
2003-09-12 |
Oxford Glycosciences (Uk) Ltd |
Novel b-cell malignancy-associated protein
|
EP2258872B1
(en)
|
2002-03-13 |
2013-08-14 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
JP3949111B2
(en)
*
|
2002-03-19 |
2007-07-25 |
田辺製薬株式会社 |
Novel G protein-coupled receptor and gene thereof
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
US7329502B2
(en)
|
2002-04-25 |
2008-02-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
|
JP2004041003A
(en)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
New protein, its dna and use thereof
|
AU2003238178A1
(en)
|
2002-05-29 |
2003-12-12 |
Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
DE60336227D1
(en)
*
|
2002-06-06 |
2011-04-14 |
Oncotherapy Science Inc |
Genes and proteins related to human colonic cancer
|
ATE545651T1
(en)
|
2002-06-13 |
2012-03-15 |
Novartis Vaccines & Diagnostic |
VECTORS FOR EXPRESSING HML-2 POLYPEPTIDES
|
WO2004009626A1
(en)
*
|
2002-07-22 |
2004-01-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel gene associated with rheumatoid arthritis
|
AU2003256074B2
(en)
|
2002-08-14 |
2011-02-03 |
National Institute Of Advanced Industrial Science And Technology |
Novel N-acetylgalactosamine transferases and nucleic acids encoding the same
|
WO2004016733A2
(en)
*
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
WO2004020662A2
(en)
*
|
2002-08-27 |
2004-03-11 |
Epigenomics Ag |
Method and nucleic acids for the analysis of breast cell proliferative disorders
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
AU2003260966A1
(en)
|
2002-09-30 |
2004-04-23 |
Japan As Represented By The President Of The University Of Tokyo |
Genes and polypeptides relating to human pancreatic cancers
|
EP1552310A2
(en)
*
|
2002-10-17 |
2005-07-13 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
EP1570080A4
(en)
|
2002-11-15 |
2006-03-01 |
Genomic Health Inc |
Gene expression profiling of egfr positive cancer
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
US7326768B2
(en)
|
2003-02-05 |
2008-02-05 |
Juan Saus |
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
EP1445614A1
(en)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A method for the in vitro assessment of the progression status of an HIV virus in an invidual
|
US7074891B2
(en)
*
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
EP1597391B1
(en)
|
2003-02-20 |
2008-10-29 |
Genomic Health, Inc. |
Use of intronic rna to measure gene expression
|
WO2004078784A1
(en)
*
|
2003-03-04 |
2004-09-16 |
Astellas Pharma Inc. |
Novel gene relating to fibrotic conditions
|
EP2248899B8
(en)
*
|
2003-03-19 |
2015-07-15 |
Biogen MA Inc. |
NOGO receptor binding protein
|
ITRM20030149A1
(en)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD
|
ES2488845T5
(en)
|
2003-06-24 |
2017-07-11 |
Genomic Health, Inc. |
Prediction of the probability of cancer recurrence
|
US7526387B2
(en)
|
2003-07-10 |
2009-04-28 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
EP2311468B1
(en)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gene overexpressed in cancer
|
WO2005018554A2
(en)
*
|
2003-08-12 |
2005-03-03 |
Washington University In St. Louis |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
TW200517503A
(en)
*
|
2003-09-10 |
2005-06-01 |
Japan Science & Tech Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
EP1667712B1
(en)
*
|
2003-10-02 |
2010-07-21 |
GlaxoSmithKline Biologicals S.A. |
B. pertussis antigens and use thereof in vaccination
|
RU2006114694A
(en)
|
2003-10-03 |
2007-11-10 |
Брихэм Энд Уимен`З Хоспитал (Us) |
TIM-3-POLYPEPTIDES
|
WO2005040791A2
(en)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
ES2380340T3
(en)
*
|
2003-12-05 |
2012-05-10 |
Northwestern University |
Self-assembling peptide amphiphiles and related methods for the administration of growth factors
|
DE602004031368D1
(en)
|
2003-12-23 |
2011-03-24 |
Genomic Health Inc |
UNIVERSAL REPRODUCTION OF FRAGMENTED RNA
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
CA2560696C
(en)
*
|
2004-03-02 |
2019-06-25 |
The Johns Hopkins University |
Mutations of the pik3ca gene in human cancers
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
AU2005229434B2
(en)
*
|
2004-03-30 |
2010-09-30 |
Nsgene A/S |
Therapeutic use of a growth factor, NsG33
|
EP2947160B1
(en)
|
2004-04-09 |
2017-07-12 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
WO2005118832A2
(en)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
|
AU2005258335B2
(en)
|
2004-06-24 |
2011-03-17 |
Biogen Ma Inc. |
Treatment of conditions involving demyelination
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
ATE433991T1
(en)
*
|
2004-08-05 |
2009-07-15 |
Toagosei Co Ltd |
CROHN'S DISEASE ANTIBODY EPITOPE PEPTIDE AND REAGENT FOR TESTING FOR CROHN'S DISEASE
|
US7930104B2
(en)
|
2004-11-05 |
2011-04-19 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
AU2005304878B2
(en)
|
2004-11-05 |
2010-07-08 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
US9200079B2
(en)
|
2004-11-12 |
2015-12-01 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
CA2598251A1
(en)
|
2005-03-04 |
2006-09-14 |
Northwestern University |
Angiogenic heparin binding peptide amphiphiles
|
WO2006120019A2
(en)
*
|
2005-05-13 |
2006-11-16 |
Centre National De La Recherche Scientifique |
Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
|
MX2008000253A
(en)
|
2005-07-08 |
2008-04-02 |
Biogen Idec Inc |
Sp35 antibodies and uses thereof.
|
EP1907589A4
(en)
*
|
2005-07-26 |
2010-11-24 |
Siemens Healthcare Diagnostics |
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
|
US8207128B2
(en)
*
|
2005-09-28 |
2012-06-26 |
Supadelixir Inc. |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
ATE480559T1
(en)
|
2005-12-14 |
2010-09-15 |
Licentia Ltd |
USES OF A NEUROTROPHIC FACTOR
|
EP2044216A2
(en)
*
|
2006-07-03 |
2009-04-08 |
Exonhit Therapeutics SA |
Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
|
WO2008030559A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
GB0805159D0
(en)
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
CN105566450A
(en)
|
2007-07-27 |
2016-05-11 |
伊玛提克斯生物技术有限公司 |
Novel immunogenic epitopes for immunotherapy
|
US7863021B2
(en)
*
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
WO2009034661A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Method for diagnosis and induction of resistance to virus
|
DK2216340T3
(en)
|
2007-10-17 |
2013-03-11 |
Univ Cordoba |
Isoforms of Alternative Treatment Human Type 5 Somatostatin Receptors and Oligonucleotide Pairs for Detection thereof by PCR
|
EP3825329A1
(en)
|
2007-12-26 |
2021-05-26 |
Xencor, Inc. |
Fc variants with altered binding to fcrn
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
ES2584438T3
(en)
*
|
2008-03-21 |
2016-09-27 |
Universiteit Hasselt |
Biomarkers for rheumatoid arthritis
|
DK2982695T3
(en)
|
2008-07-09 |
2019-05-13 |
Biogen Ma Inc |
COMPOSITIONS CONCERNING ANTIBODIES AGAINST LINGO OR FRAGMENTS THEREOF
|
EP2195013B1
(en)
|
2008-07-24 |
2011-11-02 |
NsGene A/S |
Therapeutic use of a growth factor, metrnl
|
ES2536465T3
(en)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composition of tumor-associated and cancer-related peptides for the treatment of glioblastoma (GBM) and other cancers
|
AU2009313808B2
(en)
|
2008-11-14 |
2013-05-16 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
CA2745849A1
(en)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
|
EP2419116A1
(en)
|
2009-04-13 |
2012-02-22 |
North Western University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
JP6210685B2
(en)
*
|
2010-01-27 |
2017-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
KR20130130709A
(en)
|
2010-09-29 |
2013-12-02 |
어젠시스 인코포레이티드 |
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
WO2012041328A1
(en)
|
2010-10-01 |
2012-04-05 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
US9168284B2
(en)
|
2010-12-14 |
2015-10-27 |
Sveinbjorn Gizurarson |
Biological activity of placental protein 13
|
CN104105501B
(en)
|
2011-09-05 |
2017-10-20 |
霍巴治疗公司 |
Allodynia, hyperalgia, the treatment of spontaneous pain and phantom pain
|
AR088699A1
(en)
*
|
2011-11-09 |
2014-06-25 |
Sanofi Sa |
DIACILGLICEROL LIPASA AND USES OF THE SAME
|
ES2938182T3
(en)
|
2012-04-30 |
2023-04-05 |
Biocon Ltd |
Targeting/immunomodulatory fusion proteins and methods of preparation thereof
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
JP2015518829A
(en)
|
2012-05-14 |
2015-07-06 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
LINGO-2 antagonist for treatment of conditions involving motor neurons
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
WO2014075788A1
(en)
|
2012-11-13 |
2014-05-22 |
Biontech Ag |
Agents for treatment of claudin expressing cancer diseases
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
US9023353B2
(en)
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
BR112015024752A2
(en)
|
2013-03-27 |
2017-07-18 |
Cedars Sinai Medical Center |
mitigation and reversal of fibrosis and inflammation through inhibition of tl1a function and related signaling pathways
|
HUE056760T2
(en)
|
2013-07-11 |
2022-03-28 |
Modernatx Inc |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
EP4105236A1
(en)
|
2013-07-19 |
2022-12-21 |
Cedars-Sinai Medical Center |
Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease
|
CA2925106C
(en)
|
2013-09-25 |
2023-11-14 |
Cytomx Therapeutics, Inc. |
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
|
US20160367651A1
(en)
|
2013-10-01 |
2016-12-22 |
Mie University |
T cell inducing vaccine containing an interepitope sequence that promotes antigen presentation
|
IL294782B2
(en)
|
2014-01-31 |
2023-10-01 |
Cytomx Therapeutics Inc |
Matriptase and u-plasminogen activator polypeptide substrates and other cleanable moieties, compositions comprising same and uses thereof
|
MX2017009038A
(en)
|
2015-01-08 |
2017-10-25 |
Biogen Ma Inc |
Lingo-1 antagonists and uses for treatment of demyelinating disorders.
|
MA41374A
(en)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF
|
EP3307070A4
(en)
*
|
2015-06-12 |
2019-01-02 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
PT3344776T
(en)
|
2015-09-04 |
2021-08-03 |
Synthetic Genomics Inc |
Microorganisms engineered for increased productivity
|
US11186872B2
(en)
|
2016-03-17 |
2021-11-30 |
Cedars-Sinai Medical Center |
Methods of diagnosing inflammatory bowel disease through RNASET2
|
US20200330606A1
(en)
*
|
2016-03-29 |
2020-10-22 |
Valkyrie Therapeutics Inc. |
Modulation of structural maintenance of chromosome-1 expression
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
EP3508499A1
(en)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof
|
US20220372138A1
(en)
|
2019-07-05 |
2022-11-24 |
Iomx Therapeutics Ag |
Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
|
WO2021083958A1
(en)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Novel peptides inducing satiety
|
EP4149952A1
(en)
*
|
2020-05-12 |
2023-03-22 |
Institut Curie |
Neoantigenic epitopes associated with sf3b1 mutations
|
WO2022008027A1
(en)
|
2020-07-06 |
2022-01-13 |
Iomx Therapeutics Ag |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
AU2022209669A1
(en)
*
|
2021-01-21 |
2023-08-10 |
Erasmus University Medical Center Rotterdam |
T cells for use in therapy
|
US20220260597A1
(en)
*
|
2021-02-18 |
2022-08-18 |
Beren Therapeutics P.B.C. |
Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
|
WO2023225602A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|